Pharmacoeconomic assessment of antipsychotic treatment in outpatients with schizophrenia

The aim: to provide a comprehensive pharmacoeconomic evaluation of the antipsychotic maintenance therapy in outpatients diagnosed with schizophrenia.Materials and methods. The analysis was conducted in two mutually complementary stages: an epidemiological study on the management of outpatients with...

Full description

Bibliographic Details
Published in:	Фармакоэкономика
Main Authors:	I. A. Vilyum, B. V. Andreev, M. A. Proskurin, Yu. E. Balykina
Format:	Article
Language:	Russian
Published:	IRBIS LLC 2018-05-01
Subjects:	pharmacotherapy of schizophrenia classical antipsychotics atypical antipsychotics cost-effectiveness analysis budget impact analysis
Online Access:	https://www.pharmacoeconomics.ru/jour/article/view/225

Similar Items

Pharmacoeconomic analysis of using typical and atypical antipsychotics in schizophrenia
by: I. A. Vilyum, et al.
Published: (2018-08-01)

Atypical antipsychotics in the treatment of schizophrenia
by: Swiss Medical Weekly
Published: (2003-02-01)

Systematic review of pharmacoeconomic models for schizophrenia
by: Junwen Zhou, et al.
Published: (2018-01-01)

Risk factors for pneumonia in patients with schizophrenia
by: Takahiro Haga, et al.
Published: (2018-12-01)

Pharmacogenetics and Schizophrenia—Can Genomics Improve the Treatment with Second-Generation Antipsychotics?
by: Olga Płaza, et al.
Published: (2022-12-01)

A single blind comparative clinical study of the effects of chlorpromazine and risperidone on positive and negative symptoms in patients of schizophrenia
by: Amrita Prakash Singam, et al.
Published: (2011-01-01)

Clozapine: A special case of an atypical antipsychotic
by: Elina Marinho
Published: (2024-04-01)

Genetic Testing for Antipsychotic Pharmacotherapy: Bench to Bedside
by: Mujeeb U. Shad
Published: (2021-06-01)

Cytokine Level Changes in Schizophrenia Patients with and without Metabolic Syndrome Treated with Atypical Antipsychotics
by: Anastasiia S. Boiko, et al.
Published: (2021-05-01)

Comparative effectiveness of clozapine and non-clozapine atypical antipsychotics provided by the Brazilian National Health System in adults with schizophrenia
by: Júlio César Menezes Vieira, et al.
Published: (2024-06-01)

Atypical Antipsychotics Induced Metabolic Syndrome
by: Aysegul Demirel, et al.
Published: (2015-03-01)

Which antipsychotics can we use for obsessive-compulsive symptoms in schizophrenia?
by: A. Aissa, et al.
Published: (2021-04-01)

Early non-response as a predictor of later non-response to antipsychotics in schizophrenia: a randomized trial
by: Yujun Long, et al.
Published: (2023-07-01)

Pattern of Antipsychotics in Schizophrenia Outpatients at Lampung Province Mental Hospital
by: Isnenia Isnenia
Published: (2022-03-01)

Atypical antipsychotics and sexual functions in schizophrenia: A cross-sectional study
by: Charanpreet Singh, et al.
Published: (2024-01-01)

Short-term efficacy and safety of lurasidone versus placebo in antipsychotic-naïve versus previously treated adolescents with an acute exacerbation of schizophrenia
by: Christoph U. Correll, et al.
Published: (2022-01-01)

The efficacy, acceptability, and safety of five atypical antipsychotics in patients with first-episode drug-naïve schizophrenia: a randomized comparative trial
by: Congjie Wang, et al.
Published: (2017-12-01)

COST AND EFFECTIVENESS OF ATYPICAL-ATYPICAL ANTIPSYCHOTIC COMBINATIONS AND ATYPICAL-TYPICAL ANTIPSYCHOTIC COMBINATIONS IN PATIENTS OF PSYCHOTIC DISORDERS IN INSTALLATION OF EMERGENCY IN GRHASIA MENTAL HOSPITAL, YOGYAKARTA
by: Arya Dibyo Adisaputra, et al.
Published: (2021-11-01)

Efficacy of atypical antipsychotics in schizophrenia patients: effects of 5-HTR SNPs
by: Keying Liu, et al.
Published: (2025-02-01)

Schizophrenia: effects of aripiprazole in metabolic syndrome
by: Deborah Galvão Coelho da Silva, et al.
Published: (2019-11-01)

Association of typical and atypical antipsychotics with mortality in older adults with schizophrenia: a 5-year multicenter prospective study
by: Raphaëlle Haddad, et al.
Published: (2025-08-01)

A pharmacoeconomic analysis of sertindole in the treatment of schizophrenia
by: I. S. Krysanov, et al.
Published: (2018-05-01)

Hyperhomocysteinemia in Treatment with Atypical Antipsychotics is Independent of Metabolic Syndrome
by: Emre Sarandöl, et al.
Published: (2023-12-01)

The impact of atypical antipsychotics on the development of type 2 diabetes mellitus
by: Sabina E. Kurtmambetova, et al.
Published: (2024-04-01)

Effectiveness of antipsychotic medication in patients with schizophrenia in a real world retrospective observational study in Ethiopia
by: Mulualem Kelebie, et al.
Published: (2025-02-01)

Study of factors associated with obesity in patients using antipsychotics in schizophrenia
by: Vishalakshi Patnam, et al.
Published: (2024-12-01)

The Effect of Antipsychotics on Cognition in Schizophrenia—A Current Narrative Review
by: Petru Fabian Lungu, et al.
Published: (2024-04-01)

Can atypical antipsychotic drugs cause hepatotoxicity?
by: R. André, et al.
Published: (2021-04-01)

Polypharmacy Management of Antipsychotics in Patients with Schizophrenia
by: Hiroyuki Kamei
Published: (2022-11-01)

Altered mitochondrial lymphocyte in overweight schizophrenia patients treated with atypical antipsychotics and its association with cognitive function
by: Yaoyao Zhang, et al.
Published: (2024-01-01)

The influence of typical and atypical antipsychotics on neurocognitive functions in patients with psychotic disorders
by: Javorac Jovan M., et al.
Published: (2019-01-01)

Early Markers in Resistant Schizophrenia: Effect of the First Antipsychotic Drug
by: Georgi Panov Panov
Published: (2022-03-01)

Effectiveness of antipsychotics in schizophrenia with comorbid substance use disorder
by: M. Lähteenvuo, et al.
Published: (2021-04-01)

Onset of Action of Selected Second-Generation Antipsychotics (Pines)–A Systematic Review and Meta-Analyses
by: Rikke Meyer, et al.
Published: (2022-12-01)

Study of adverse effects of extrapyramidal syndrome use of combination of antipsychotics antidepressants in outpatient schizophrenia patients in RSUP Fatmawati for the period 2016-2020
by: Ema Nillafita Putri Kusuma, et al.
Published: (2023-07-01)

Prescription of Anticholinergic Drugs in Patients With Schizophrenia: Analysis of Antipsychotic Prescription Patterns and Hospital Characteristics
by: Hikaru Hori, et al.
Published: (2022-05-01)

Sexual differences in the clinical features of antipsychotic-induced hyperprolactinemia in patients with schizophrenia
by: E. G. Kornetova, et al.
Published: (2019-10-01)

Anti-stress Properties of Atypical Antipsychotics
by: Alice Sanson, et al.
Published: (2020-10-01)

Comparison of antipsychotic prescribing practices following failure of antipsychotic monotherapy in the acute care setting
by: Kaitlyn Morgan, PharmD, BCPP, et al.
Published: (2023-01-01)

The Effect of Aspirin on Schizophrenia; A Double Blind Placebo Controlled Study
by: Hamidreza Jamilian, Gevick Hacoupian
Published: (2017-12-01)